常見皮膚病 列表

亞急性皮膚型紅斑狼瘡(subacute cutaneous lupus erythematosus, SCLE)(1p)
閱覽:1355   

亞急性皮膚型紅斑狼瘡。以皮膚症狀為主的紅斑狼瘡特殊亞型,屬系統性紅斑鋃瘡和慢性盤狀紅斑狼瘡的中間型,是相對良性的全身性疾病皮膚損害,主要為丘疹鱗屑型,和環形多環形兩種形態,與SLE、DLE同樣有TYK2, IRF5 及CTLA4 genes的遺傳異常。多數伴隨anti-Ro/SSA autoantibodies,好發族群包括ancestral haplotype HLA1, B8, DR3, DQ2, DRw52 and C4 null, deficiencies of C1q, C2 and C4 components of complement 及TNF-α–308 polymorphism。主要分布在光照部位(頭頸部,V字部位)。亞急性皮膚型紅斑狼瘡可能由藥物誘發,包括胃藥(PPI)及抗黴菌藥terbinafine。奎寧是主要的治療, 使用此療法應戒煙以免影響療效。最近也有以 etanercept成功治療的報告。

Antihypertensives 40/117(34·2%)
Calcium channel blockers
   Diltiazem                                                            6 cases
   Verapamil                            5 cases
   Nifedipine                        3 cases
   Nitrendipine                     1 case
Diuretics
   Hydrochorothiazide                                            10 cases
   Hydrochlorothiazide + triamterene                             3 cases
   Chlorthiazide                            2 cases
Beta blockers
   Oxprenolo                            4 cases
   Acebutolol                          1 case
Angiotensin-converting enzyme inhibitors
   Enalapri                         2 cases
   Lisnopril                            1 case
   Captopril                             1 case
   Cilazapril                             1 case
Antifungals 30/117 (25·6%)
   Terbinafine                                                         29 cases
   Griseofulvin                                                     1 case
Chemotherapeutics 10/117 (8·5%)
   Docetaxe                           3 cases
   Paclitaxel                             3 cases
   Tamoxifen                            2 cases
   Capecitabine                             2 cases
Antihistamines 9/117 (7·7%)
   Ranitidine                                                             7 cases
   Brompheniramine                            1 case
   Cinnarizine + thiethylperazine                          1 case
Immunomodulators 8/117 (6·8%)
   Leflunomide                                                 5 cases
   Interferon α and β                       3 cases
Antiepileptics 3/117 (2·6%)
   Carbamazepine                             2 cases
   Phenytoin                                                              1 case
Statins 3/117 (2·6%)
   Simvastatin                             2 cases
   Pravastatin                             1 case
Biologics 2/117 (1·7%)
   Etanercept                               50 1 case
   Efalizumab                             1 case
Proton pump inhibitors 2/117 (1·7%)
   Lansoprazole                             2 cases
Nonsteroidal anti-inflammatory drugs 2/117 (1·7%)
   Naproxen                             1 case
   Piroxicam                                                              1 case
Hormone-altering drugs 2/117 (1·7%)
   Leuprorelin                             1 case
   Anastrozole                             1 case
Ultraviolet therapy 2/117 (1·7%)
   PUVA                             1 case
   PUVA and UVB                             1 case
Others 4/117 (3·4%)
   Bupropion                             1 case
   Tiotropium                             1 case
   Ticlopidine1 case
   Hay with fertilizer                             1 case
張貼日期:2007/8/14